Evaluating patients on immune checkpoint inhibitors for cardiac adverse events: The EPICC study
- DOI
- 10.1177/10781552251349459
- Published
- 2025-06-23
- Container
- Journal of Oncology Pharmacy Practice
- Publisher
- SAGE Publications
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1177/10781552251349459,
title = {Evaluating patients on immune checkpoint inhibitors for cardiac adverse events: The EPICC study},
author = {Kong Vang and Jennifer Panich and Connie Folz and Hiral Patel and Nikhila Aimalla and Yuanli Lei and Thane Drier and Paige Hergenrother and Somto Nwaedozie and Chady A Leon},
year = {2025},
journal = {Journal of Oncology Pharmacy Practice},
doi = {10.1177/10781552251349459},
url = {https://doi.org/10.1177/10781552251349459}
}RIS
TY - JOUR TI - Evaluating patients on immune checkpoint inhibitors for cardiac adverse events: The EPICC study AU - Kong Vang AU - Jennifer Panich AU - Connie Folz AU - Hiral Patel AU - Nikhila Aimalla AU - Yuanli Lei AU - Thane Drier AU - Paige Hergenrother AU - Somto Nwaedozie AU - Chady A Leon PY - 2025 JO - Journal of Oncology Pharmacy Practice DO - 10.1177/10781552251349459 UR - https://doi.org/10.1177/10781552251349459 ER -
APA
Vang, K., Panich, J., Folz, C., Patel, H., Aimalla, N., Lei, Y., Drier, T., Hergenrother, P., Nwaedozie, S., & Leon, C. A. (2025). Evaluating patients on immune checkpoint inhibitors for cardiac adverse events: The EPICC study. Journal of Oncology Pharmacy Practice. https://doi.org/10.1177/10781552251349459
Source records
- crossref · retrieved 2026-09-25T11:51:46.079Z